Publication: 70

Publication: 70

Phase I study of temsirolimus (CCI-779) and sorafenib in recurrent glioblastoma: North central cancer treatment group (NCCTG) N0572

URL

Google Scholar

Citation:: Neuro-oncology vol 9 (4) 518-518

Meeting Instance:: SNO 2007
Year:: 2007
Type:: Abstract
Sub type:: Poster General
Funding:: NCTN
Endpoint:: Primary
Analysis:: Preliminary
Data Sharing:: No-Data-Sharing
Status:: Presented/Published
Citation Status:: pub

Note:

Methodological:: No
Biospecimen:: No
SDC:: No

Parents:: None
Children:: 2773

Program:: OGC
Primary Committee:: Neuro-Onc
Sec. Committees:

Pharmas:
Grants:

Corr. Author:
Authors:: D. Schiff J. Sarkaria P. Decker J. Buckner E. Galanis J. Dancey C. Giannini P. Brown M. Wiesenfeld K. Jaeckle

Networks:

Study: NCCTG-N0572
Multiple Studies, or Legacy Studies in Alliance Study:
Phases:: 1/2

Keywords: